Bevicra 100mg Bevacizumab Injection

Bevicra 100mg Bevacizumab Injection is a targeted anti-cancer medication used to treat various types of cancer, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It contains Bevacizumab, a monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF), a protein that promotes the formation of blood vessels that nourish tumors. By reducing the tumor’s blood supply, Bevicra 100mg Bevacizumab Injection helps slow cancer growth and limit its spread. Administered as an intravenous infusion by healthcare professionals, it is often used in combination with chemotherapy or other cancer therapies to enhance treatment outcomes. Regular monitoring is important during treatment to assess effectiveness and manage potential side effects. Patients should use Bevicra 100mg Injection only under the guidance and supervision of their oncologist.